{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

3rd Annual Mount Sinai MASH/MASLD Center of Excellence Symposium

Overview
Register
Faculty

Add to Calendar 3rd Annual Mount Sinai MASH/MASLD Center of Excellence Symposium 10/10/2025 8:00:00 AM 10/10/2025 5:00:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/MASH25 Description: Practitioners and researchers who are experts in the field of MASH will discuss current developments in the field. The intended audience includes primary care providers, endocrinologists, advanced practitioners, gastroenterologists, hepatologists, and others actively engaged in the diagnosis and management of MASH. Online false MM/DD/YYYY

Date & Location

Friday, October 10, 2025, 8:00 AM - 5:00 PM, Online

Target Audience

Specialties - Liver Diseases, Primary Care Physician

Course Overview

Practitioners and researchers who are experts in the field of MASH will discuss current developments in the field. The intended audience includes primary care providers, endocrinologists, advanced practitioners, gastroenterologists, hepatologists, and others actively engaged in the diagnosis and management of MASH.

Objectives

Understand risk stratification, outcomes, and management.
Analyze how to interpret and appropriately apply results of non-invasive tests for MASLD/MASH to diverse patient populations

Accreditation

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credits

AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Anna Mageras, MPH
Mount Sinai
Sunnyside, NY

Course Director

Grant or research support-Gilead Sciences, Inc.|Grant or research support-Pfizer (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Gilead (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novo Nordisk (Relationship has ended)|Grant or research support-Petauri

Meena B. Bansal, MD

Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Course Director, Faculty

Advisor-Madrigal, Novo, Fibronostics, The Kinetix Group, Merck, Boeheringer-Inghelheim, Curve Bio, GSK|Consulting Fee-Madrigal, GSK, NovoNordisk, Fibronostics, Merck, Boeheringer-Ingelheim, CurveBio|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Madrigal, NOVO Nordisk|Grant or research support-Histoindex, Pfizer

Scott L. Friedman, MD

Fishberg Professor of Medicine, Liver Diseases and Pharmacological Sciences
Icahn School of Medicine a Mount Sinai
New York, NY

Course Director, Faculty

Manal F Abdelmalek, MD, MPH, Professor of Medicine
Director, NAFLD Clinical Research
Mayo Clinic
Rochester, MN

Faculty

Michael Betel, MSc, CGC
Fatty Liver Alliance
Toronto, Canada

Faculty

Honoraria-Novo Nordisk|Honoraria-Boehringer Ingelheim Boehringer Ingelheim|Advisor-Regeneron Regeneron|Advisor-Madrigal

Andrea Branch, PhD
New York, NY

Faculty

Fernando Carnavali, MD
MD
MSM-MSW
New York, NY

Faculty

Jaime Chu, MD
Icahn School of Medicine at Mount Sinai
Manhasset, NY

Faculty

Anu Lala-Trinadade, MD

Assistant Professor of Cardiology, Population Health Science and Policy
The Mount Sinai Hospital
Edgewater, NJ

Faculty

Carmen L Lazala, MD
Briggs Family Pediatrics
Scarsdale, NY

Faculty

Jeffrey Lazarus, MD

Faculty

Tae Hoon Lee, MD
Bronx VAMC
Bronx, NY

Faculty

FRANCES LEE
Icahn School of Medicine
New York, NY

Faculty

Nothing to disclose

Pruthvi Patel, MD
Mount sinai
New york , NY

Faculty

Mary Rinella, MD
Professor of Medicine
University of Chicago Medicine
Chicago, IL

Faculty

Jorn Schattenberg, MD
UKS
Homburg, Germany

Faculty

Reshmi Srinath, MD
Assistant Professor of Medicine, Endocrinology
Icahn School of Medicine at Mount Sinai
New York, NY

Faculty

Grant or research support-Dexcom (Relationship has ended)

Bachir Taouli, MD

Professor, Department of Radiology, Translational and Molecular Imaging Institute (TMII)
Icahn School of Medicine at Mount Sinai
New York, NY

Faculty

Friday, October 10, 2025

Introduction--the BIG Picture Metabolic Dysfunction Associated Steatohepatitis (MASH)
8:00AM - 8:15AM
Scott L. Friedman, MD

Hot Topics EASL and DDW Review
8:15AM - 8:35AM
Manal F Abdelmalek, MD, MPH, Professor of Medicine

Cracking the Code Making the Diagnosis, Risk Stratification, and Prognosis Prediction in MASLD/MASH
8:35AM - 8:55AM
Meena B. Bansal, MD

It’s All About the Genes Role of Genetics in Determining Risk of Fibrosis and Liver Cancer
8:55AM - 9:15AM
Andrea Branch, PhD

Just Have to Have It: Common Themes of Addiction: GLP1s to the rescue? Me t-ALD: Emerging data and role of GLP-1 RA and other therapies
9:15AM - 9:35AM
FRANCES LEE

Seeing is Believing Overview of Imaging Modalities for the Assessment of MASLD/MASH
9:35AM - 10:00AM
Bachir Taouli, MD

Break
10:00AM - 10:15AM

The Clues Within: Powering the Future with AI Leveraging New AI algorithms for Risk Stratification and Prediction of Outcomes
10:15AM - 10:35AM
Jorn Schattenberg, MD

Eye of the Storm Intersection of Genetics, Lifestyle, and Environment in Pediatric MASLD/MASH
10:35AM - 10:55AM
Jaime Chu, MD

It is All About Engagement MASH cities: Engaging policy makers, payors, and patients to drive awareness and need f or screening high-risk populations
10:55AM - 11:10AM
Jeffrey Lazarus, MD

Screening for MASLD/MASH from PCP perspective
11:10AM - 11:30AM
Fernando Carnavali, MD

How to Talk with Patients Workshop
11:30AM - 12:15PM
Michael Betel, MSc, CGC

Lunch
12:15PM - 1:00PM

Empowering Change Lifestyle, Medical, and Surgical Management of Obesity and Diabetes, and their R ole in the Management of Patients with MASLD/MASH
1:00PM - 1:20PM
Reshmi Srinath, MD

Finding a Needle in a Haystack MASLD/MASH and HCC
1:20PM - 1:40PM
Tae Hoon Lee, MD

We Have a Drug for That Targeting Thyroid Hormone-B Signaling and Other Emerging Therapies (Focus on FGF-21 Class)
1:40PM - 2:00PM
Meena B. Bansal, MD

Going Gangster and Beyond GLP -1/GIP/GlucRA (G, Double GG, Triple GGG)-Mechanism of Action and their impact on MASH
2:00PM - 2:20PM
Mary Rinella, MD

The Crystal Ball Predicting and Managing Cardiovascular Risk in Patients with MASLD/MASH
2:20PM - 2:45PM
Anu Lala-Trinadade, MD

Break
2:45PM - 3:00PM

Ask the Experts Meena B. Bansal, MD Making Sense of It All (Case Based Discussion) and Open Q and A from attendees
3:00PM - 4:00PM
Meena B. Bansal, MD